Navigation Links
Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
Date:11/1/2012

PARSIPPANY, N.J., Nov. 1, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income for the third quarter 2012 increased 24.2 percent to $172.3 million or $1.35 per diluted share on a non-GAAP basis, compared to $138.7 million or $1.09 per diluted share in the third quarter 2011.  Non-GAAP net income for the third quarter 2012 included $6.7 million or $0.05 per share related to the favorable settlement of a tax audit and other tax benefits realized in the quarter. Net revenue increased 18.8 percent to $1.29 billion, compared to $1.08 billion in the third quarter 2011. On a GAAP basis, net income increased by $8.6 million or 13 percent to $76.7 million or $0.60 per diluted share compared to earnings of $68.1 million or $0.54 per diluted share in the third quarter 2011. 

For the third quarter 2012, adjusted EBITDA increased 18 percent to $304.6 million, compared to $258.2 million in the third quarter 2011.  Refer to the attached reconciliation tables for adjustments to GAAP earnings.  Cash flow from operations was $145.9 million and cash and marketable securities were $234.4 million at September 30, 2012.

"Our third quarter 2012 double digit growth in global revenues, non-GAAP earnings and adjusted EBITDA represents another quarter of solid growth and strong execution at Watson," said Paul Bisaro, President and CEO. "We are very pleased that as we transition from Watson stand-alone to a larger company following the Actavis acquisition, we have demonstrated outstanding execution of our 2012 business plan. We delivered this performance while we simultaneously focused on integration planning and are now ready to capitalize on our objectives for uniting Watson and Actavis, and creating a larger, more powerful global competitor."

"During the quarter, Watson received a number of important FDA approvals including generic
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
2. Watson to Acquire Actavis Group for EUR4.25 Billion
3. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
4. Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
5. Watson Confirms Lo Loestrin® Fe Patent Challenge
6. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
7. Watson Confirms Testim® Patent Challenge
8. Watson to Present at the Jefferies 2012 Global Healthcare Conference
9. Watson Announces Lidoderm® Patent Challenge Settlement
10. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
11. Watson to Host Second Quarter 2012 Earnings Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 Accelovance, Inc. (Accelovance), a global ... and General Medicine announced the completion of enrollment ... Heron Therapeutics, Inc. for the Phase 3 trial ... candidate SUSTOL® (granisetron injection, extended release) as part ... 1 receptor antagonist fosaprepitant and IV corticosteroid ...
(Date:7/7/2015)... 2015 Research and ... the "Deciphering Global Major Pharmaceutical Companies, New ... offering. It has been publicly recognized ... in a series of challenges in the recent ... significant overcapacities in small molecule product manufacturing; increasingly ...
(Date:7/7/2015)... 2015  PAREXEL International Corporation (NASDAQ: PRXL ) will ... 2015 on Wednesday, August 5 th , 2015 after the ... on PAREXEL,s website at www.PAREXEL.com and on the ... host a conference call and live webcast at 10:00 a.m. ... the results.  To access the webcast, visit PAREXEL,s website at ...
Breaking Medicine Technology:Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2
... Cancer Patients With Improved Potential,to Battle Their ... --,Arrowhead Research Corporation announced today that two ... Calando,Pharmaceuticals Inc., are presenting data at the ... Meeting. The,presentations summarize the latest research findings ...
... ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Introgen Therapeutics,Inc. (NASDAQ:INGN) ... Los Angeles, California at the Annual Meeting of ... p53 tumor suppressor is one of the most,common ... action is targeted to restoring p53 tumor suppressor,function ...
Cached Medicine Technology:Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 2Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 3Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
(Date:7/7/2015)... Dallas, TX (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable ... Panama vs. Haiti and the United States vs. Honduras at the Toyota Stadium. ... today, July 7th at Toyota Stadium. The tournament, being held on American soil, will ...
(Date:7/7/2015)... ... ... The United States Centers for Disease Control and Prevention have awarded Fenway ... Coalition $3.78 million for a five-year HIV prevention partnership that will focus on ... the groups at highest risk of HIV infection in the US. Dubbed ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois ... board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) ... industry forward and are committed to making sure patients have access to cannabis ...
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting revolutionary purity limits for ... Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of ... to test every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched ...
(Date:7/7/2015)... ... 07, 2015 , ... On Saturday, May 16th, 2015, the Manistee, MI chapter ... Country Club. Best Drug Rehabilitation staff members were delighted to join in for this ... International, the parent of the Manistee Kiwanis Club, is a global organization that works ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2
... lining of the womb may be damaged by heavy smoking, ... recent research. // ,The study revealed that smoking ... of the uterus difficult. ,The study was published ... rates for IVF using donated eggs for those who either ...
... have for the first time implicated the muscle protein myosin ... ,In a series of lab studies with human ... overproduction of myosin VI in both prostate tumor cells and ... 'silence' myosin VI, they discovered the cells were less able ...
... made from soy could play an important dietary role ... blood pressure, suggests new findings by University of Massachusetts ... Amherst scientists screened extracts from a sampling of dairy ... diabetes and hypertension in check, such as the activity ...
... transplants when they treated animals suffering from eye damages. // ... to that seen in many human eye diseases. They were ... their sight, leading to hopes that it could also benefit ... retinal stem cells were transplanted into the eye of the ...
... on-line consultations as an important additional tool in doctors' ... areas. // ,AMA President, Dr Mukesh Haikerwal, said ... that technology will add to medical encounters in the ... Statement on On-Line and Other Broadband Connected Medical Consultations, ...
... endemic among wild gorillas in Africa and its source of ... //,Statistics have shown that around 40 million people worldwide are ... with simian immunodeficiency virus (SIV) are said to be the ... in humans the source of the third has been unknown, ...
Cached Medicine News:Health News:'Muscle' Protein Drives Prostate Cancer 2Health News:Fruit Yogurt Could Play An Important Role In Diabetes Management 2Health News:Fruit Yogurt Could Play An Important Role In Diabetes Management 3Health News:Fruit Yogurt Could Play An Important Role In Diabetes Management 4Health News:Cell Transplants Can Even Help In Restoring Vision 2Health News:E-Consultations Given Go-Ahead 2Health News:Monkey Virus Identical to HIV Endemic in Gorillas 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: